Spring 2020 D.C. Advocacy Days
Adrian Hayes2020-01-21T13:30:43-05:00In March of 2019, KidneyCAN sponsored the Kidney Cancer Advocacy Day in D.C. This successful event was attended by more than 20
Do Something: The Importance of Patient Advocacy in Healthcare
Adrian Hayes2020-01-06T19:04:57-05:00"What strikes me about these individuals and many others I have met in the community is the personal will to
KCRP – Kidney Cancer Research Program (CDMRP)
Bryan Lewis2019-08-16T11:14:26-04:00Representatives of KidneyCan and the AUA (American Urological Association) visited with the Kidney Cancer Research Program staff at Ft. Detrick, Maryland recently
Kidney Cancer Champion
Bryan Lewis2019-08-02T18:11:40-04:00Meeting with Cong. Nita Lowey (NY) at her district office in White Plains, NY
$30 Million for Kidney Cancer Research
Bryan Lewis2019-05-21T10:04:21-04:00The U.S. House Appropriations Committee released its report accompanying the FY20 Defense Appropriations Act. It contains an increase to $30 million
IKCC Global Kidney Cancer Summit 2019
Bryan Lewis2019-04-06T20:05:48-04:00Our President, Bryan Lewis represented KidneyCan at the 9th global summit for Kidney Cancer in Lisbon, Portugal. IKCC (International Kidney Cancer
First In Human Trial for Kidney Cancer: Watching and Waiting
Brenda Knapp2019-04-06T20:44:57-04:00The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we're in the watching and waiting phase.
Clinical trials are vital to Medical Research
Brenda Knapp2019-03-30T17:54:28-04:00My husband is participating in a first in human or Phase 1 clinical trial. This trial is for kidney cancer and
NCI Leader in Kidney Cancer
Bryan Lewis2019-03-30T14:25:14-04:00Bryan Lewis, Ralph & Brenda Knapp, founders of KidneyCan had the pleasure of sitting down with
Letter submitted to Congressional Leadership
Brenda Knapp2019-03-29T16:35:04-04:00KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered